Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating myelodysplastic syndrome

Methods of treating myelodysplastic syndrome

US Patent 12171778 · Granted Dec 24, 2024

Estimated economic value: $52,826,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

FGFR2 inhibitors for the treatment of cholangiocarcinoma2025
Methods of treating myelodysplastic syndrome2025
Methods of treating myelodysplastic syndrome2025
Treatment of cholangiocarcinoma2024
FGFR2 inhibitors for the treatment of cholangiocarcinoma2023
Combination treatment for hematological cancers2022
Combination therapy comprising glucose reabsorption inhibitors and PPAR modulato2012
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X re2012
Substituted amino acids as erythropoietin mimetics2008
Substituted amino acids as erythropoietin mimetics2006
Combination therapy comprising glucose reabsorption inhibitors and retinoid-X re2005
Substituted amino acids as erythropoietin mimetics2004